摘要
目的研究糖尿病肾病与非糖尿病肾病血液透析中急慢性并发症治疗效果。方法选择2016年6月—2021年4月79例于该院接受血液透析的患者展开研究,根据患者疾病类型将其分为对照组(非糖尿病肾病患者,共40例)和观察组(糖尿病肾病患者,共39例)。两组均接受血液透析治疗,对比急慢性并发症发生情况、存活率等。结果急性并发症的对比,观察组低血糖、低血压发生率较对照组更高,差异有统计学意义(P<0.05);慢性并发症的对比,观察组骨病、感染、心血管病变、高血压发生率较对照组更高,差异有统计学意义(P<0.05);比较两组存活情况可知,观察组3年、5年存活率均低于对照组,差异有统计学意义(P<0.05);在观察组患者中,存活率≥3年患者首次接受透析前尿素氮水平、血清肌酐水平较存活率<3年患者更低,差异有统计学意义(t=2.722、2.352,P<0.05),而血红白蛋水平高于存活率不足3年者,差异有统计学意义(P<0.05)。结论糖尿病肾病患者在血液透析期间更易发生急慢性并发症,应对其尽早开展血液透析治疗,加强对并发症的监控和预防,以进一步提高患者生存率。
Objective To study the therapeutic effects of acute and chronic complications in hemodialysis for diabetic nephropathy and non-diabetic nephropathy.Methods 79 patients who received hemodialysis from June 2016 to April 2021 in this hospital were selected for the study.The patients were divided into control group(non-diabetic nephropathy patients,total 40 cases)and observation group(diabetic nephropathy patients,total 39 cases)according to their disease types.Both groups received hemodialysis and compared their acute and chronic complications,survival rate,etc.Results Compared with acute complications,the incidence of hypoglycemia and hypotension in the observation group was higher than that in the control group,and the difference was statistically significant(P<0.05).In comparison of chronic complications,the incidence of bone disease,infection,and cardiovascular disease and hypertension in the observation group was higher than that in the control group,and the difference was statistically significant(P<0.05).Comparing the survival conditions of the two groups,the 3-year and 5-year survival rates of the observation group were lower than those of the control group,and the difference was statistically significant(P<0.05).In the observation group,patients with a survival rate of≥3 years before receiving dialysis for the first time had lower levels of urea nitrogen and serum creatinine than those with a survival rate of less than 3 years,and the difference was statistically significant(t=2.722,2.352,P<0.05).The hemoglobin level was higher than the survival rate for less than 3 years,the difference was statistically significant(P<0.05).Conclusion Patients with diabetic nephropathy are more likely to have acute and chronic complications during hemodialysis.Hemodialysis treatment should be carried out as soon as possible,and the monitoring and prevention of complications should be strengthened to further improve the survival rate of patients.
作者
陈独立
陈金新
陈志忠
CHEN Duli;CHEN Jinxin;CHEN Zhizhong(Blood Purification Center,Putian Medical District,900th Hospital of Joint Logistics Support Force,Putian,Fujian Province,351100 China)
出处
《糖尿病新世界》
2021年第24期38-40,65,共4页
Diabetes New World Magazine
关键词
糖尿病肾病
血液透析
急性并发症
慢性并发症
非糖尿病肾病
Diabetic nephropathy
Hemodialysis
Acute complications
Chronic complications
Non-diabetic nephr opathy
